The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis-Reference-Cited by-同舟云学术

The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis

Published:2023-09 Issue:3 Volume:164 Page:741-747
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Kotch Chelsea^ORCID,Si Stephanie J.,Desai Kavita,Caminada Philippe,Lo Russo Francesco Maria,Li Yimei,Liu Grant T.,Avery Robert A.,Fisher Michael J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-023-04468-3.pdf

Reference16 articles.

1. Campen CJ, Gutmann DH (2018) Optic pathway gliomas in neurofibromatosis type 1. J Child Neurol 33:73–81. https://doi.org/10.1177/0883073817739509

2. Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 14:790–797. https://doi.org/10.1093/neuonc/nos076

3. Avery RA, Ferner RE, Listernick R, Fisher MJ, Gutmann DH, Liu GT (2012) Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research. J Neurooncol 110:1–7. https://doi.org/10.1007/s11060-012-0944-y

4. Kotch C, Avery R, Getz KD, Bouffet E, de Blank P, Listernick R, Gutmann DH, Bornhorst M, Campen C, Liu GT, Aplenc R, Li Y, Fisher MJ (2022) Risk factors for treatment refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1. Neuro Oncol. https://doi.org/10.1093/neuonc/noac013

5. Azizi AA, Walker DA, Liu JF, Sehested A, Jaspan T, Pemp B, Simmons I, Ferner R, Grill J, Hargrave D, Driever PH, Evans DG, Opocher E, Siope Nf1 Opg Nottingham UKW (2021) NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat. Neuro Oncol 23:100–111. https://doi.org/10.1093/neuonc/noaa153

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions;Child's Nervous System;2024-05-05